Ask for a traceable order journey, not merely an API claim. Photon’s documentation, for example, distinguishes sent, filling, shipped and delivered states; its webhook documentation warns that events can be duplicated or arrive out of order. These are useful test cases, not evidence that a particular clinic integration is working. (docs.photon.health)
Use a synthetic or appropriately protected test set covering:
- Prescription received but awaiting clarification.
- Eligibility or payment failure.
- Patient cancellation before fulfilment.
- Shipment created but not collected by the carrier.
- Delivery failure or temperature concern.
- Duplicate and out-of-order status events.
- An amended prescription and cancellation of the superseded order.
- Transfer to an alternative pharmacy.
- Export of open and completed orders at contract exit.
Reconcile the clinic, platform and pharmacy records. Confirm which event proves delivery and which merely proves label creation.
For patient service, assign responsibility at every handoff: who explains the charge, who contacts the patient about missing information, who resolves a delivery exception, and who provides clinical or pharmacist support. Keep nonclinical service targets in the weighted score; missing clinical escalation remains a gate issue.
FDA reports concerns involving warm shipments and fraudulent labels naming pharmacies that did not make the product. Accordingly, the proposed exception test should verify both the temperature-review pathway and the ability to confirm the actual dispensing/compounding source. (fda.gov)
Sources cited on this page
- docs.photon.health · Source 1 ↗https://docs.photon.health/docs/order-events?utm_source=openai
- fda.gov · Source 2 ↗https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss?be78ca04_page=4&24dc8be8_page=2&2485ce93_page=2&315591c6_page=2